| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlorides | 24 | 2024 | 663 | 5.950 |
Why?
|
| Epilepsy | 47 | 2024 | 3267 | 4.200 |
Why?
|
| Hippocampus | 57 | 2024 | 3738 | 3.430 |
Why?
|
| Neurons | 51 | 2024 | 9426 | 2.920 |
Why?
|
| Seizures | 28 | 2024 | 2917 | 2.830 |
Why?
|
| Bumetanide | 11 | 2022 | 96 | 2.640 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 11 | 2022 | 150 | 2.250 |
Why?
|
| Action Potentials | 29 | 2024 | 1816 | 2.160 |
Why?
|
| gamma-Aminobutyric Acid | 17 | 2021 | 1132 | 1.990 |
Why?
|
| Symporters | 8 | 2024 | 361 | 1.970 |
Why?
|
| Receptors, GABA-A | 17 | 2014 | 621 | 1.870 |
Why?
|
| Nerve Net | 14 | 2018 | 2261 | 1.470 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 10 | 2024 | 104 | 1.390 |
Why?
|
| Synapses | 22 | 2018 | 1757 | 1.320 |
Why?
|
| Chloride Channels | 7 | 2014 | 221 | 1.300 |
Why?
|
| Synaptic Transmission | 13 | 2021 | 1171 | 1.280 |
Why?
|
| Anticonvulsants | 18 | 2023 | 1879 | 1.270 |
Why?
|
| Organ Culture Techniques | 13 | 2017 | 796 | 1.180 |
Why?
|
| Neocortex | 5 | 2023 | 416 | 1.130 |
Why?
|
| Brain Injuries | 8 | 2023 | 2044 | 1.070 |
Why?
|
| Phenobarbital | 6 | 2020 | 189 | 1.050 |
Why?
|
| Neural Inhibition | 11 | 2015 | 589 | 1.000 |
Why?
|
| Pyramidal Cells | 11 | 2018 | 369 | 1.000 |
Why?
|
| Rats | 63 | 2017 | 23711 | 0.990 |
Why?
|
| Electroencephalography | 24 | 2024 | 6189 | 0.970 |
Why?
|
| Kainic Acid | 12 | 2024 | 199 | 0.860 |
Why?
|
| Miller Fisher Syndrome | 1 | 2022 | 6 | 0.830 |
Why?
|
| Membrane Potentials | 18 | 2014 | 1095 | 0.810 |
Why?
|
| Dextrans | 1 | 2024 | 574 | 0.780 |
Why?
|
| Animals, Newborn | 14 | 2021 | 2672 | 0.770 |
Why?
|
| Animals | 116 | 2024 | 167963 | 0.770 |
Why?
|
| Ophthalmoplegia | 1 | 2022 | 168 | 0.740 |
Why?
|
| Disease Models, Animal | 28 | 2024 | 18137 | 0.730 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2022 | 125 | 0.730 |
Why?
|
| Rats, Sprague-Dawley | 27 | 2017 | 8158 | 0.690 |
Why?
|
| Models, Neurological | 8 | 2018 | 1758 | 0.660 |
Why?
|
| Brain | 23 | 2023 | 26951 | 0.660 |
Why?
|
| Cytoplasm | 2 | 2021 | 1516 | 0.620 |
Why?
|
| Mannitol | 1 | 2019 | 180 | 0.620 |
Why?
|
| Convulsants | 4 | 2010 | 70 | 0.600 |
Why?
|
| Thalamus | 2 | 2016 | 1041 | 0.560 |
Why?
|
| Cell Death | 6 | 2023 | 1672 | 0.550 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 592 | 0.550 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 8 | 2008 | 893 | 0.550 |
Why?
|
| Status Epilepticus | 6 | 2010 | 456 | 0.540 |
Why?
|
| Excitatory Amino Acid Antagonists | 8 | 2013 | 448 | 0.530 |
Why?
|
| Diuretics | 2 | 2011 | 613 | 0.510 |
Why?
|
| Interneurons | 6 | 2015 | 591 | 0.500 |
Why?
|
| Excitatory Postsynaptic Potentials | 8 | 2018 | 369 | 0.500 |
Why?
|
| Brain Waves | 3 | 2018 | 401 | 0.490 |
Why?
|
| Infant, Premature | 1 | 2024 | 2092 | 0.480 |
Why?
|
| Patch-Clamp Techniques | 7 | 2018 | 932 | 0.480 |
Why?
|
| Brain Edema | 2 | 2017 | 603 | 0.480 |
Why?
|
| Neuronal Plasticity | 6 | 2013 | 1430 | 0.450 |
Why?
|
| Human papillomavirus 16 | 1 | 2015 | 265 | 0.430 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 2221 | 0.410 |
Why?
|
| Water | 1 | 2019 | 1407 | 0.410 |
Why?
|
| Dentate Gyrus | 3 | 2009 | 163 | 0.410 |
Why?
|
| Kynurenic Acid | 5 | 2013 | 44 | 0.410 |
Why?
|
| Biological Clocks | 2 | 2011 | 316 | 0.400 |
Why?
|
| Epilepsy, Benign Neonatal | 2 | 2008 | 13 | 0.390 |
Why?
|
| Mice | 27 | 2024 | 81208 | 0.380 |
Why?
|
| Presynaptic Terminals | 3 | 2018 | 301 | 0.360 |
Why?
|
| Dendrites | 3 | 2004 | 475 | 0.360 |
Why?
|
| Cerebral Cortex | 9 | 2015 | 5761 | 0.350 |
Why?
|
| Papilledema | 1 | 2011 | 130 | 0.330 |
Why?
|
| Pseudotumor Cerebri | 1 | 2011 | 108 | 0.330 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1726 | 0.330 |
Why?
|
| Percussion | 1 | 2008 | 18 | 0.320 |
Why?
|
| Brain Chemistry | 3 | 2018 | 959 | 0.320 |
Why?
|
| Surgical Equipment | 1 | 2008 | 57 | 0.320 |
Why?
|
| Telemetry | 6 | 2010 | 199 | 0.310 |
Why?
|
| Electrophysiology | 8 | 2010 | 1265 | 0.310 |
Why?
|
| Picrotoxin | 3 | 2009 | 62 | 0.310 |
Why?
|
| Periodicity | 2 | 2007 | 348 | 0.310 |
Why?
|
| DNA, Viral | 1 | 2015 | 2194 | 0.300 |
Why?
|
| Signal Transduction | 7 | 2016 | 23376 | 0.300 |
Why?
|
| Entorhinal Cortex | 2 | 2013 | 286 | 0.290 |
Why?
|
| Leigh Disease | 1 | 2008 | 89 | 0.290 |
Why?
|
| Evoked Potentials | 6 | 2013 | 1036 | 0.290 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2007 | 63 | 0.280 |
Why?
|
| Glutamic Acid | 4 | 2007 | 1167 | 0.270 |
Why?
|
| Bicarbonates | 2 | 1999 | 292 | 0.270 |
Why?
|
| Cortical Synchronization | 1 | 2006 | 77 | 0.270 |
Why?
|
| Probability | 1 | 2011 | 2475 | 0.270 |
Why?
|
| Time Factors | 18 | 2024 | 40165 | 0.260 |
Why?
|
| Acetazolamide | 3 | 2012 | 96 | 0.260 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2010 | 664 | 0.260 |
Why?
|
| Cell Membrane | 2 | 2014 | 3682 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2448 | 0.250 |
Why?
|
| Estrous Cycle | 1 | 2005 | 65 | 0.250 |
Why?
|
| Potassium | 3 | 2004 | 1313 | 0.250 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2058 | 0.250 |
Why?
|
| Electric Stimulation | 7 | 2013 | 1735 | 0.240 |
Why?
|
| GABA Antagonists | 4 | 2012 | 120 | 0.240 |
Why?
|
| Neurofibromatoses | 1 | 2009 | 299 | 0.240 |
Why?
|
| Mitochondrial Diseases | 1 | 2008 | 340 | 0.240 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2008 | 387 | 0.230 |
Why?
|
| Coloring Agents | 2 | 2024 | 562 | 0.230 |
Why?
|
| Halogens | 1 | 2024 | 13 | 0.230 |
Why?
|
| Ion Transport | 4 | 2009 | 318 | 0.230 |
Why?
|
| Cannabinoids | 1 | 2006 | 173 | 0.230 |
Why?
|
| Hypoventilation | 1 | 2024 | 44 | 0.230 |
Why?
|
| Mice, Transgenic | 8 | 2024 | 9530 | 0.230 |
Why?
|
| Analysis of Variance | 6 | 2014 | 6238 | 0.230 |
Why?
|
| Myotonia Congenita | 1 | 2023 | 16 | 0.230 |
Why?
|
| Nervous System Diseases | 3 | 2020 | 1647 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 2864 | 0.220 |
Why?
|
| Malignant Hyperthermia | 1 | 2023 | 71 | 0.220 |
Why?
|
| Calcium | 6 | 2024 | 5725 | 0.220 |
Why?
|
| Rats, Wistar | 8 | 2004 | 1850 | 0.220 |
Why?
|
| Neural Pathways | 3 | 2011 | 3040 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 22023 | 0.210 |
Why?
|
| Headache | 1 | 2011 | 1249 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2014 | 3735 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2014 | 10827 | 0.210 |
Why?
|
| Apnea | 1 | 2024 | 195 | 0.210 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 663 | 0.200 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2008 | 781 | 0.200 |
Why?
|
| Fragile X Syndrome | 1 | 2023 | 116 | 0.200 |
Why?
|
| Phenytoin | 2 | 2013 | 188 | 0.200 |
Why?
|
| Protein Subunits | 1 | 2005 | 943 | 0.190 |
Why?
|
| Piperidines | 1 | 2010 | 1650 | 0.190 |
Why?
|
| Potassium Channels | 1 | 2004 | 534 | 0.190 |
Why?
|
| Amygdala | 1 | 2009 | 1351 | 0.190 |
Why?
|
| Equipment Design | 2 | 2010 | 3520 | 0.190 |
Why?
|
| Drug Hypersensitivity | 1 | 2010 | 916 | 0.190 |
Why?
|
| Humans | 58 | 2024 | 760621 | 0.190 |
Why?
|
| Drugs, Investigational | 2 | 2013 | 214 | 0.190 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2005 | 701 | 0.190 |
Why?
|
| Neurons, Afferent | 1 | 2003 | 498 | 0.180 |
Why?
|
| Luminescent Proteins | 2 | 2015 | 835 | 0.180 |
Why?
|
| Infant, Newborn | 7 | 2024 | 26181 | 0.180 |
Why?
|
| Cytosol | 1 | 2024 | 887 | 0.180 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2013 | 1347 | 0.180 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2022 | 311 | 0.180 |
Why?
|
| Male | 43 | 2024 | 359744 | 0.180 |
Why?
|
| Recovery of Function | 1 | 2010 | 2985 | 0.170 |
Why?
|
| Ataxia | 1 | 2022 | 305 | 0.170 |
Why?
|
| Pyrazoles | 1 | 2010 | 1999 | 0.170 |
Why?
|
| Stroke | 5 | 2021 | 9962 | 0.170 |
Why?
|
| Sodium Chloride Symporters | 1 | 2019 | 10 | 0.170 |
Why?
|
| Propionates | 3 | 2009 | 182 | 0.160 |
Why?
|
| Diuretics, Osmotic | 1 | 2019 | 33 | 0.160 |
Why?
|
| 2-Amino-5-phosphonovalerate | 3 | 2007 | 58 | 0.160 |
Why?
|
| Excitatory Amino Acid Agonists | 4 | 2009 | 143 | 0.160 |
Why?
|
| Computer Simulation | 5 | 2018 | 6218 | 0.160 |
Why?
|
| Hematoma, Subdural, Intracranial | 1 | 2018 | 30 | 0.160 |
Why?
|
| Epilepsy, Rolandic | 1 | 2019 | 54 | 0.160 |
Why?
|
| Antiporters | 1 | 1999 | 278 | 0.150 |
Why?
|
| Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.150 |
Why?
|
| Advisory Committees | 2 | 2023 | 788 | 0.150 |
Why?
|
| Algorithms | 6 | 2018 | 13981 | 0.150 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2022 | 620 | 0.150 |
Why?
|
| Cleft Palate | 1 | 2023 | 587 | 0.150 |
Why?
|
| Phagocytosis | 1 | 2023 | 1535 | 0.150 |
Why?
|
| Disease Progression | 4 | 2018 | 13502 | 0.140 |
Why?
|
| Gold | 2 | 2012 | 484 | 0.140 |
Why?
|
| Adenoviridae | 2 | 2000 | 1084 | 0.140 |
Why?
|
| Scalp | 1 | 2019 | 389 | 0.130 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2012 | 55 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 4 | 2013 | 4407 | 0.130 |
Why?
|
| Neurosciences | 1 | 2020 | 353 | 0.130 |
Why?
|
| Feedback, Psychological | 1 | 2015 | 95 | 0.130 |
Why?
|
| Indoles | 1 | 2023 | 1829 | 0.120 |
Why?
|
| Culture Media | 1 | 2017 | 900 | 0.120 |
Why?
|
| Biological Transport | 2 | 2014 | 2086 | 0.120 |
Why?
|
| Recurrence | 4 | 2010 | 8482 | 0.120 |
Why?
|
| Microglia | 1 | 2023 | 1351 | 0.120 |
Why?
|
| Cell Membrane Permeability | 2 | 2014 | 575 | 0.120 |
Why?
|
| Receptors, AMPA | 2 | 2006 | 323 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase (Cytochrome) | 1 | 2013 | 1 | 0.110 |
Why?
|
| Electrodes | 3 | 2010 | 614 | 0.110 |
Why?
|
| Microelectrodes | 3 | 2008 | 304 | 0.110 |
Why?
|
| Glutamate Decarboxylase | 2 | 2012 | 239 | 0.110 |
Why?
|
| Riluzole | 1 | 2013 | 58 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2015 | 1900 | 0.110 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2013 | 54 | 0.110 |
Why?
|
| Biphenyl Compounds | 2 | 2008 | 992 | 0.110 |
Why?
|
| GABA-A Receptor Antagonists | 3 | 2003 | 60 | 0.110 |
Why?
|
| Adenosine | 2 | 2009 | 834 | 0.100 |
Why?
|
| Pattern Recognition, Automated | 2 | 2010 | 994 | 0.100 |
Why?
|
| Phosphinic Acids | 1 | 2012 | 17 | 0.100 |
Why?
|
| Thioglycolates | 1 | 2012 | 38 | 0.100 |
Why?
|
| Barbiturates | 1 | 1992 | 113 | 0.100 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2020 | 352 | 0.100 |
Why?
|
| Neurology | 1 | 2020 | 779 | 0.100 |
Why?
|
| Clinical Trials as Topic | 3 | 2020 | 8056 | 0.100 |
Why?
|
| Lactic Acid | 2 | 2017 | 1134 | 0.100 |
Why?
|
| Electric Conductivity | 4 | 1998 | 410 | 0.100 |
Why?
|
| Swine | 4 | 2024 | 5899 | 0.100 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2011 | 33 | 0.100 |
Why?
|
| Propanolamines | 1 | 2012 | 162 | 0.100 |
Why?
|
| Emergency Medical Service Communication Systems | 1 | 2011 | 21 | 0.100 |
Why?
|
| Axons | 2 | 2013 | 1673 | 0.090 |
Why?
|
| GABA Plasma Membrane Transport Proteins | 1 | 2010 | 29 | 0.090 |
Why?
|
| Genetic Vectors | 2 | 2000 | 3380 | 0.090 |
Why?
|
| Nanocapsules | 1 | 2012 | 92 | 0.090 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2013 | 629 | 0.090 |
Why?
|
| Ambulances | 1 | 2011 | 92 | 0.090 |
Why?
|
| Extracellular Fluid | 2 | 2009 | 165 | 0.090 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2010 | 127 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2014 | 638 | 0.090 |
Why?
|
| Intracellular Fluid | 1 | 2010 | 201 | 0.090 |
Why?
|
| Valine | 1 | 2012 | 409 | 0.090 |
Why?
|
| Choline | 1 | 2012 | 513 | 0.090 |
Why?
|
| Lidocaine | 1 | 2013 | 538 | 0.090 |
Why?
|
| Emergency Medical Services | 3 | 2011 | 1925 | 0.090 |
Why?
|
| Anti-Anxiety Agents | 1 | 1992 | 397 | 0.090 |
Why?
|
| Fetal Monitoring | 1 | 1990 | 69 | 0.090 |
Why?
|
| Female | 18 | 2020 | 391270 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 6068 | 0.080 |
Why?
|
| Granulocytes | 1 | 1991 | 551 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 961 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 829 | 0.080 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 2660 | 0.080 |
Why?
|
| Cells, Cultured | 8 | 2023 | 18957 | 0.080 |
Why?
|
| Intracranial Hemorrhages | 2 | 2020 | 844 | 0.080 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 15289 | 0.080 |
Why?
|
| Apoptosis | 2 | 2023 | 9501 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 494 | 0.080 |
Why?
|
| Papillomaviridae | 1 | 2015 | 1117 | 0.080 |
Why?
|
| Caspases | 1 | 2012 | 878 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2015 | 1967 | 0.080 |
Why?
|
| Rotation | 1 | 2010 | 514 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2362 | 0.080 |
Why?
|
| Gene Expression | 3 | 1997 | 7588 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2016 | 1928 | 0.080 |
Why?
|
| Lethargy | 1 | 2008 | 43 | 0.080 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2008 | 60 | 0.080 |
Why?
|
| Video Recording | 2 | 2013 | 955 | 0.080 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 1411 | 0.080 |
Why?
|
| Pain | 1 | 2003 | 5066 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1722 | 0.080 |
Why?
|
| Age Factors | 4 | 2021 | 18416 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11071 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1077 | 0.070 |
Why?
|
| Cell Count | 1 | 2012 | 1835 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 1991 | 708 | 0.070 |
Why?
|
| Magnesium Deficiency | 1 | 2008 | 48 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2015 | 1802 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2012 | 1608 | 0.070 |
Why?
|
| Quinoxalines | 2 | 2004 | 297 | 0.070 |
Why?
|
| Strontium | 1 | 2007 | 21 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.070 |
Why?
|
| Neurofibromin 1 | 1 | 2009 | 190 | 0.070 |
Why?
|
| Monitoring, Physiologic | 3 | 2010 | 1784 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 1991 | 748 | 0.070 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2008 | 184 | 0.070 |
Why?
|
| Receptors, Cannabinoid | 1 | 2006 | 43 | 0.070 |
Why?
|
| Hypothermia | 1 | 2008 | 188 | 0.070 |
Why?
|
| Dura Mater | 1 | 2008 | 290 | 0.070 |
Why?
|
| Feedback | 2 | 2001 | 791 | 0.070 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1990 | 529 | 0.070 |
Why?
|
| Models, Biological | 3 | 2008 | 9467 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2012 | 2502 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2852 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2008 | 599 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 616 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2014 | 2208 | 0.070 |
Why?
|
| Metabolomics | 1 | 2015 | 1628 | 0.070 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2010 | 347 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1972 | 0.070 |
Why?
|
| Artifacts | 2 | 2023 | 1898 | 0.070 |
Why?
|
| Sirolimus | 1 | 2013 | 1547 | 0.070 |
Why?
|
| Aging | 2 | 2003 | 8651 | 0.060 |
Why?
|
| Long-Term Potentiation | 1 | 2007 | 293 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2009 | 9287 | 0.060 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 399 | 0.060 |
Why?
|
| Cerebral Infarction | 1 | 2010 | 982 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 544 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2009 | 1489 | 0.060 |
Why?
|
| Pressure | 1 | 2008 | 1156 | 0.060 |
Why?
|
| Neurophysiology | 1 | 2006 | 144 | 0.060 |
Why?
|
| Rats, Long-Evans | 1 | 2005 | 378 | 0.060 |
Why?
|
| Pilocarpine | 1 | 2004 | 64 | 0.060 |
Why?
|
| Mutation | 3 | 2016 | 29932 | 0.060 |
Why?
|
| Thiazoles | 1 | 2012 | 1511 | 0.060 |
Why?
|
| Kinetics | 2 | 2004 | 6377 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 6498 | 0.060 |
Why?
|
| Culture Techniques | 3 | 1994 | 530 | 0.060 |
Why?
|
| Craniotomy | 1 | 2008 | 741 | 0.060 |
Why?
|
| Astrocytes | 1 | 2012 | 1338 | 0.060 |
Why?
|
| Ion Channels | 3 | 1994 | 1043 | 0.060 |
Why?
|
| Livestock | 1 | 2023 | 20 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2008 | 1754 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1832 | 0.060 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 1091 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 1689 | 0.060 |
Why?
|
| Software | 1 | 2017 | 4419 | 0.060 |
Why?
|
| Microfluidics | 1 | 2008 | 652 | 0.050 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2010 | 806 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2019 | 42063 | 0.050 |
Why?
|
| Papillomavirus Infections | 1 | 2015 | 1607 | 0.050 |
Why?
|
| tau Proteins | 1 | 2013 | 2085 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15840 | 0.050 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2003 | 86 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2003 | 105 | 0.050 |
Why?
|
| Pentobarbital | 1 | 2003 | 153 | 0.050 |
Why?
|
| Rats, Inbred Strains | 3 | 1992 | 2094 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 858 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2010 | 1328 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3726 | 0.050 |
Why?
|
| Fetus | 1 | 1990 | 1859 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2012 | 6360 | 0.050 |
Why?
|
| Phantom Limb | 1 | 2003 | 96 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 707 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 476 | 0.050 |
Why?
|
| Protein Transport | 1 | 2007 | 1964 | 0.050 |
Why?
|
| Spinal Cord | 2 | 2003 | 1817 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2021 | 1110 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2009 | 1197 | 0.050 |
Why?
|
| Wakefulness | 1 | 2008 | 1255 | 0.050 |
Why?
|
| Adolescent | 6 | 2019 | 87810 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2005 | 1146 | 0.050 |
Why?
|
| Off-Road Motor Vehicles | 1 | 2001 | 17 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 3707 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 3604 | 0.050 |
Why?
|
| GABA Modulators | 1 | 2020 | 109 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2013 | 65017 | 0.040 |
Why?
|
| Porosity | 2 | 2012 | 349 | 0.040 |
Why?
|
| Meningoencephalitis | 1 | 2020 | 83 | 0.040 |
Why?
|
| North Carolina | 2 | 2011 | 325 | 0.040 |
Why?
|
| Glycine | 1 | 2003 | 662 | 0.040 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2000 | 144 | 0.040 |
Why?
|
| Accidents | 1 | 2001 | 166 | 0.040 |
Why?
|
| Drug Resistance | 3 | 2013 | 1617 | 0.040 |
Why?
|
| Research Design | 2 | 2013 | 6180 | 0.040 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1999 | 103 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2023 | 1578 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5794 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 1993 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2008 | 1540 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2005 | 5075 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2009 | 2629 | 0.040 |
Why?
|
| Fluoresceins | 2 | 2009 | 234 | 0.040 |
Why?
|
| Causality | 1 | 2005 | 1242 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 244 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 4048 | 0.040 |
Why?
|
| DNA Repair | 1 | 2008 | 2039 | 0.040 |
Why?
|
| Receptor, Adenosine A1 | 2 | 2009 | 42 | 0.040 |
Why?
|
| Memory | 1 | 2006 | 2179 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2009 | 14372 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2008 | 3106 | 0.030 |
Why?
|
| Ganglia, Spinal | 2 | 1996 | 523 | 0.030 |
Why?
|
| Artificial Intelligence | 2 | 2010 | 2557 | 0.030 |
Why?
|
| Infant | 3 | 2009 | 36060 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 601 | 0.030 |
Why?
|
| Sodium | 1 | 2001 | 1594 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 412 | 0.030 |
Why?
|
| Muscimol | 1 | 1995 | 70 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2009 | 3127 | 0.030 |
Why?
|
| Amiloride | 1 | 1995 | 116 | 0.030 |
Why?
|
| Adult | 6 | 2023 | 219994 | 0.030 |
Why?
|
| Bicuculline | 2 | 1992 | 96 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2022 | 12766 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 5785 | 0.030 |
Why?
|
| Prosencephalon | 1 | 1997 | 305 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 8547 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 418 | 0.030 |
Why?
|
| Receptors, Glycine | 1 | 1994 | 33 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17790 | 0.030 |
Why?
|
| Language | 1 | 2023 | 1533 | 0.030 |
Why?
|
| Septum Pellucidum | 1 | 1994 | 54 | 0.030 |
Why?
|
| Learning | 1 | 2023 | 1739 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2005 | 2714 | 0.030 |
Why?
|
| Tetrodotoxin | 2 | 1991 | 246 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1994 | 202 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2007 | 6414 | 0.030 |
Why?
|
| Parasympathetic Nervous System | 1 | 1994 | 141 | 0.030 |
Why?
|
| Drug Interactions | 2 | 2009 | 1428 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12965 | 0.030 |
Why?
|
| Middle Aged | 4 | 2018 | 220352 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 11903 | 0.030 |
Why?
|
| Comorbidity | 2 | 2021 | 10551 | 0.030 |
Why?
|
| GABA Agents | 1 | 2012 | 41 | 0.030 |
Why?
|
| Kindling, Neurologic | 1 | 1992 | 24 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1997 | 4490 | 0.030 |
Why?
|
| Scrapie | 1 | 1991 | 21 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 58741 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mos | 1 | 1991 | 17 | 0.030 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 1 | 1991 | 10 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1992 | 174 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 2012 | 80 | 0.030 |
Why?
|
| Magnesium | 1 | 1995 | 810 | 0.020 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2013 | 326 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2012 | 161 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 309 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 1992 | 229 | 0.020 |
Why?
|
| Genes, Synthetic | 1 | 1991 | 88 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 7818 | 0.020 |
Why?
|
| Gases | 1 | 2012 | 203 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2008 | 36290 | 0.020 |
Why?
|
| Neural Conduction | 1 | 1992 | 441 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1994 | 562 | 0.020 |
Why?
|
| DNA Primers | 1 | 1995 | 2819 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1995 | 1955 | 0.020 |
Why?
|
| Diffusion | 1 | 2012 | 813 | 0.020 |
Why?
|
| Prions | 1 | 1991 | 179 | 0.020 |
Why?
|
| Texas | 1 | 2011 | 401 | 0.020 |
Why?
|
| Logistic Models | 2 | 2018 | 13314 | 0.020 |
Why?
|
| Adenosine A1 Receptor Antagonists | 1 | 2009 | 27 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1992 | 406 | 0.020 |
Why?
|
| Silver | 1 | 2010 | 120 | 0.020 |
Why?
|
| Xanthines | 1 | 2009 | 122 | 0.020 |
Why?
|
| Time | 1 | 2011 | 545 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2013 | 699 | 0.020 |
Why?
|
| Behavior, Animal | 2 | 2008 | 1866 | 0.020 |
Why?
|
| Child | 4 | 2023 | 79806 | 0.020 |
Why?
|
| Aconitum | 1 | 2008 | 1 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 2477 | 0.020 |
Why?
|
| Cricetinae | 1 | 1991 | 2427 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4938 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2010 | 941 | 0.020 |
Why?
|
| Calcium Channels | 1 | 1992 | 619 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 1343 | 0.020 |
Why?
|
| Cost Savings | 1 | 2013 | 920 | 0.020 |
Why?
|
| Cell Communication | 1 | 1995 | 1653 | 0.020 |
Why?
|
| Fumarate Hydratase | 1 | 2008 | 52 | 0.020 |
Why?
|
| Deoxyguanosine | 1 | 2008 | 92 | 0.020 |
Why?
|
| Species Specificity | 1 | 1991 | 2418 | 0.020 |
Why?
|
| Base Sequence | 2 | 1996 | 12446 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8555 | 0.020 |
Why?
|
| Homeostasis | 2 | 1998 | 3306 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 848 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2008 | 333 | 0.020 |
Why?
|
| DNA Glycosylases | 1 | 2008 | 124 | 0.020 |
Why?
|
| Endothelium | 1 | 2009 | 764 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2057 | 0.020 |
Why?
|
| Neurites | 1 | 2008 | 390 | 0.020 |
Why?
|
| Amyloid | 1 | 1991 | 842 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 1992 | 1131 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12427 | 0.020 |
Why?
|
| Hypocapnia | 1 | 2005 | 38 | 0.020 |
Why?
|
| Electronics, Medical | 1 | 2006 | 72 | 0.020 |
Why?
|
| Cell Separation | 1 | 1992 | 1720 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 17624 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 755 | 0.020 |
Why?
|
| Acids | 1 | 2005 | 125 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 2932 | 0.020 |
Why?
|
| Videotape Recording | 1 | 2007 | 337 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 151 | 0.010 |
Why?
|
| Leucine | 1 | 2006 | 547 | 0.010 |
Why?
|
| Brain Stem | 1 | 1990 | 857 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 732 | 0.010 |
Why?
|
| Hypercapnia | 1 | 2005 | 261 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1544 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1500 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3094 | 0.010 |
Why?
|
| Reaction Time | 1 | 1990 | 2075 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 1019 | 0.010 |
Why?
|
| United States | 2 | 2021 | 72461 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2010 | 1004 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2006 | 1234 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2006 | 965 | 0.010 |
Why?
|
| Tyrosine | 1 | 2006 | 1438 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 832 | 0.010 |
Why?
|
| Arkansas | 1 | 2001 | 59 | 0.010 |
Why?
|
| Oocytes | 1 | 2006 | 1165 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 2000 | 76 | 0.010 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2000 | 73 | 0.010 |
Why?
|
| Linear Models | 1 | 2011 | 5877 | 0.010 |
Why?
|
| Risk Factors | 3 | 2019 | 74359 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2018 | 80372 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 20080 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15620 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2010 | 3476 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 14660 | 0.010 |
Why?
|
| Olfactory Bulb | 1 | 1998 | 198 | 0.010 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 1996 | 13 | 0.010 |
Why?
|
| Deoxycytosine Nucleotides | 1 | 1996 | 14 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4122 | 0.010 |
Why?
|
| Digoxigenin | 1 | 1996 | 26 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2006 | 1274 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1992 | 6568 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 2006 | 1268 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2000 | 755 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12808 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1996 | 420 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 1998 | 552 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1996 | 461 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 5397 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 5508 | 0.010 |
Why?
|
| Nucleosomes | 1 | 1996 | 484 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1994 | 218 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 169152 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1996 | 1247 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1996 | 1078 | 0.010 |
Why?
|
| Cerebellum | 1 | 1998 | 1496 | 0.010 |
Why?
|
| Mitosis | 1 | 1996 | 1191 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8950 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1996 | 1927 | 0.000 |
Why?
|
| Cell Division | 1 | 1996 | 4463 | 0.000 |
Why?
|
| Pregnancy | 1 | 1990 | 29749 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6216 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 58995 | 0.000 |
Why?
|
| Cell Survival | 1 | 1994 | 5797 | 0.000 |
Why?
|
| DNA | 1 | 1996 | 7233 | 0.000 |
Why?
|